Although it is commonly used in assessing patients with heart failure (HF), NT-proBNP is independently associated with risk of coronary heart disease (CHD) as well as adverse outcomes among patients with ST-elevation myocardial infarction (STEMI). This evidence concerns the gene NPPB and coronary artery disorder.